Isoniazid preventive therapy-related adverse events among Malawian adults on antiretroviral therapy: A cohort study

By rosaguerrero • October 2, 2022

Tsirizani-Galileya L, Milanzi E, Mungwira R, Divala T, Mallewa J, Mategula D, Nampota N, Mwapasa V, Buchwald A, Laurens MB, Laufer MK, Van Oosterhout JJ. Isoniazid preventive therapy-related adverse events among Malawian adults on antiretroviral therapy: A cohort study. Medicine (Baltimore). 2022 Sep 30;101(39):e30591. doi: 10.1097/MD.0000000000030591. PMID: 36181120.

Tags: Infectious Diseases, Publications

Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureusBacteremia

Chan LC, Lee HK, Wang L, Wang H, Filler SG, Ciranna A, Abdelhady W, Xiong YQ, Li L, Gonzales RA, Ruffin F, Fowler VG Jr,[...]

Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083

Landovitz RJ, Fogel JM, Gao F, Hanscom B, Piwowar-Manning E, Moser A, Marzinke MA, Cyktor J, Seisa M, Halvas EK, Kofron R, Jennings A, Clement[...]

Immune activation from M. tuberculosis screening tests predicts mortality

Seligman B, Ganz DA, Goetz MB, Beenhouwer DO. Immune activation from M. tuberculosis screening tests predicts mortality. Geroscience. 2026 Apr 27. doi: 10.1007/s11357-026-02221-y. Epub ahead[...]